Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03651128

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 109 Birmingham, Alabama, United States
  • Local Institution - 141 Scottsdale, Arizona, United States
  • Local Institution - 145 Los Angeles, California, United States
  • Local Institution - 122 Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

NCT03249870

Conditions
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP), Chromosome Aberrations, Hematologic Diseases, +14 more
Locations
  • CH Amiens sud Amiens, France
  • CHU Angers Angers, France
  • CH Victor Dupouy Argenteuil, France
  • CH cote basque Bayonne, France
View all 41 locations
View Trial Details
Completed

Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT01838434

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions